Moderna News - July 30, 2026

🟢 Moderna is trading 4% up today ahead of Q2 earnings and RSV vaccine traction

Moderna is trading 4% up today at $56.68 as investors position ahead of its Q2 2026 earnings report on July 31 and focus on early commercial traction for its...

Moderna Inc Q2 2026 Earnings Preview: What Analysts Expect on July 31, 2026

Moderna is expected to report Q2 2026 revenue of $103.1 million and an EPS loss of $1.97, with its current share price of $55.63 trading above the average...